Protein profile

PA3427

short-chain dehydrogenase

Genome: NC_002516.2

Gene: PA3427 Structure source: AlphaFold UniProt Q9HYH8
Amino acids 303
Annotations 4
Features 27
PDB binders 4
Druggability 0.416

Overview

Basic information about this protein and its source genome.

Accession
PA3427
Gene
PA3427
Status
annotated
Amino acids
303
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
67.568
Human E-value
8.75e-08
Gut microbiome off-target
hit
Essential (DEG)
N
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.416
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

4 GO

Gene Ontology (GO)

4
  • GO:0003857 Catalysis of the reaction: a (3S)-3-hydroxyacyl-CoA + NAD+ = a 3-oxoacyl-CoA + NADH + H+.
  • GO:0004300 Catalysis of the reaction: a 3-hydroxy-fatty acyl-CoA = a enoyl-CoA + H2O. This reaction usually occurs in the reverse direction, leading to the reduction of the double bound of enoyl-CoA in position 2 or 3. Specific reactions catalyzed include: a 4-saturated-(3S)-3-hydroxyacyl-CoA = a (3E)-enoyl-CoA + H2O and a (3S)-3-hydroxyacyl-CoA = a (2E)-enoyl-CoA + H2O.
  • GO:0006635 A fatty acid oxidation process that results in the complete oxidation of a long-chain fatty acid. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and occurs by successive cycles of reactions during each of which the fatty acid is shortened by a two-carbon fragment removed as acetyl coenzyme A; the cycle continues until only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.

Sequence Features

Domain/signature hits from InterPro and related databases.

27 records
Show feature table
Start End DB Term Name
185 202 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
185 202 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
11 28 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
11 28 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
91 102 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
91 102 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
138 154 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
138 154 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
208 228 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
208 228 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
164 183 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
164 183 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
5 252 SUPERFAMILY SSF51735 NAD(P)-binding Rossmann-fold domains
5 252 InterPro IPR036291 NAD(P)-binding domain superfamily
5 254 CDD cd05353 hydroxyacyl-CoA-like_DH_SDR_c-like
250 302 Gene3D G3DSA:1.10.287.4290 -
151 179 ProSitePatterns PS00061 Short-chain dehydrogenases/reductases family signature.
151 179 InterPro IPR020904 Short-chain dehydrogenase/reductase, conserved site
4 300 PANTHER PTHR45024 DEHYDROGENASES, SHORT CHAIN
10 196 Pfam PF00106 short chain dehydrogenase
10 196 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
1 249 Gene3D G3DSA:3.40.50.720 -
144 152 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
144 152 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
164 183 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
91 102 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
10 184 SMART SM00822 This enzymatic domain is part of bacterial polyketide synthases and catalyses the first step in the reductive modification of the beta-carbonyl centres in the growing polyketide chain. It uses NADPH to reduce the keto group to a hydroxy group.

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA3427
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
3 0.416
9 0.213

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

59 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
AAE Q4FRT2 102.1 Da LogP 0.05 TPSA 54.4 ✓ Ro5 ✓ Clean CC(=O)CC(=O)O
B3P B3R6T4 282.3 Da LogP -4.01 TPSA 145.4 1 viol. ✓ Clean C(CNC(CO)(CO)CO)CNC(CO)(CO)CO
CAA P14697 851.6 Da LogP -1.36 TPSA 380.7 3 viol. ✓ Clean CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)CO[P…
QT8 Q4FRT2 116.1 Da LogP 0.44 TPSA 54.4 ✓ Ro5 ✓ Clean CCC(=O)CC(=O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.